Digital Pharma Innovation Week has ended
Back To Schedule
Monday, October 26 • 11:20am - 12:05pm
Panel – Adapt or Fail: Launching a New Drug During a Pandemic

Sign up or log in to save this to your schedule, view media, leave feedback and see who's attending!

The COVID-19 pandemic landed just as some pharma companies were preparing to launch new therapies. Suddenly, after millions of dollars and years of planning, drug makers had to shift gears. So how does a pharma even begin to launch a drug under pandemic conditions? Tune into this panel to hear about the challenges, adaptations and successes from those who did it.

avatar for Kyle Blankenship

Kyle Blankenship

Associate Editor, Fierce Pharma

avatar for Alisa Lask

Alisa Lask

Vice President and General Manager, Aesthetic Business Unit, Galderma
As General Manager and Vice President of U.S. Aesthetics at Galderma, Alisa Lask oversees a portfolio of products including the iconic brand Restylane and the award-winning loyalty program Aspire Galderma Rewards. Under Alisa’s leadership, Galderma has launched seven new aesthetic... Read More →
avatar for Robert Dudley, Ph.D.

Robert Dudley, Ph.D.

Chairman, CEO and President, Clarus Therapeutics, Inc.
Robert E. Dudley, Ph.D., has served as Chief Executive Officer, President and Chairman of the Board of Directors since founding Clarus Therapeutics in 2004. As the co-inventor of multiple formulations of testosterone replacement therapies, he is a leading voice in hypogonadism and... Read More →
avatar for Renee Marotta

Renee Marotta

Executive Director of Marketing, Esperion

Monday October 26, 2020 11:20am - 12:05pm EDT